Cartilage oligomeric matrix protein specific antibodies are pathogenic

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Geng, Hui ^a,b   Nandakumar, Kutty S ^b   Pramhed, Anna ^d   Aspberg, Anders ^c,d   Mattsson, Ragnar ^d   Holmdahl, Rikard ^b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 2; EPIDERMAL GROWTH FACTOR; MONOCLONAL ANTIBODY; RECOMBINANT ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; 129 MOUSE; AMINO ACID SEQUENCE; ANIMAL; CARTILAGE; EXPERIMENTAL ARTHRITIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; CARTILAGE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA;

EID: 84865049473     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4022     Document Type: Article

References (48)

1. Reparon-Schuijt CC, van Esch WJ, van Kooten C, Schellekens GA, de Jong BA, van Venrooij WJ, Breedveld FC, Verweij CL. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001, 44:41-47. 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0, 11212174.
2. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223, 14558078.
3. Newkirk MM. Rheumatoid factors: host resistance or autoimmunity?. Clin Immunol 2002, 104:1-13. 10.1006/clim.2002.5210, 12139942.
4. Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 2005, 35:1643-1652. 10.1002/eji.200526000, 15832289.
5. Stuart JM, Dixon FJ. Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983, 158:378-392. 10.1084/jem.158.2.378, 2187334, 6886622.
6. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 1986, 29:400-410. 10.1002/art.1780290314, 2421741.
7. Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003, 163:1827-1837. 10.1016/S0002-9440(10)63542-0, 1892447, 14578183.
8. Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, Serre G, Burkhardt H, Thunnissen MM, Holmdahl R. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009, 206:449-462. 10.1084/jem.20081862, 2646582, 19204106.
9. Gellrich S, Muche JM, Wilks A, Jasch KC, Voit C, Fischer T, Audring H, Sterry W. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation. Br J Dermatol 2005, 153:167-173. 10.1111/j.1365-2133.2005.06659.x, 16029344.
10. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004, 350:2572-2581. 10.1056/NEJMoa032534, 15201414.
11. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992, 267:6132-6136.
12. Halasz K, Kassner A, Morgelin M, Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007, 282:31166-31173. 10.1074/jbc.M705735200, 17716974.
13. Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, Briggs MD. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 2001, 276:6046-6055. 10.1074/jbc.M009507200, 11087755.
14. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995, 10:330-336. 10.1038/ng0795-330, 7670472.
15. Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, Francomano CA, Prange CK, Lennon GG, Deere M. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 1995, 10:325-329. 10.1038/ng0795-325, 7670471.
16. Carlsen S, Hansson AS, Olsson H, Heinegard D, Holmdahl R. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 1998, 114:477-484. 10.1046/j.1365-2249.1998.00739.x, 1905143, 9844060.
17. Carlsen S, Nandakumar KS, Backlund J, Holmberg J, Hultqvist M, Vestberg M, Holmdahl R. Cartilage oligomeric matrix protein induction of chronic arthritis in mice. Arthritis Rheum 2008, 58:2000-2011. 10.1002/art.23554, 18576344.
18. Souto-Carneiro MM, Burkhardt H, Muller EC, Hermann R, Otto A, Kraetsch HG, Sack U, Konig A, Heinegard D, Muller-Hermelink HK, Krenn V. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein. J Immunol 2001, 166:4202-4208.
19. Mo JA, Holmdahl R. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. J Immunol 1996, 157:2440-2448.
20. Svensson L, Aszodi A, Heinegard D, Hunziker EB, Reinholt FP, Fassler R, Oldberg A. Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol Cell Biol 2002, 22:4366-4371. 10.1128/MCB.22.12.4366-4371.2002, 133870, 12024046.
21. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004, 101:12646-12651. 10.1073/pnas.0403831101, 515111, 15310853.
22. Geng H, Carlsen S, Nandakumar KS, Holmdahl R, Aspberg A, Oldberg A, Mattsson R. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis. Arthritis Res Ther 2008, 10:R134. 10.1186/ar2551, 2656236, 19014566.
23. Cao D, Khmaladze I, Jia H, Bajtner E, Nandakumar KS, Blom T, Mo JA, Holmdahl R. Pathogenic autoreactive B cells are not negatively selected toward matrix protein collagen II. J Immunol 2011, 187:4451-4458. 10.4049/jimmunol.1101378, 21940677.
24. Holmdahl RCS, Mikulowska A, Vestberg M, Brunsberg U, Hansson A-S, Sundvall M, Jansson L, Pettersson U. Genetic analysis of mouse models for rheumatoid arthritis. Human Genome Methods 1998, 215-238. New York: CRC Press, Adolph KW.
25. Klaus GG, Pepys MB, Kitajima K, Askonas BA. Activation of mouse complement by different classes of mouse antibody. Immunology 1979, 38:687-695. 1457877, 521057.
26. Neuberger MS, Rajewsky K. Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol 1981, 11:1012-1016. 10.1002/eji.1830111212, 7327198.
27. Laver WG, Air GM, Webster RG, Smith-Gill SJ. Epitopes on protein antigens: misconceptions and realities. Cell 1990, 61:553-556. 10.1016/0092-8674(90)90464-P, 1693095.
28. Davies DR, Cohen GH. Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 1996, 93:7-12. 10.1073/pnas.93.1.7, 40169, 8552677.
29. Estienne V, Duthoit C, Vinet L, Durand-Gorde JM, Carayon P, Ruf J. A conformational B-cell epitope on the C-terminal end of the extracellular part of human thyroid peroxidase. J Biol Chem 1998, 273:8056-8062. 10.1074/jbc.273.14.8056, 9525906.
30. Plotz PH. The autoantibody repertoire: searching for order. Nat Rev Immunol 2003, 3:73-78. 10.1038/nri976, 12511877.
31. Saxne T, Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992, 31:583-591. 10.1093/rheumatology/31.9.583, 1381980.
32. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997, 36:1151-1160. 10.1093/rheumatology/36.11.1151, 9402858.
33. Liu CJ, Kong W, Xu K, Luan Y, Ilalov K, Sehgal B, Yu S, Howell RD, Di Cesare PE. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem 2006, 281:15800-15808. 10.1074/jbc.M513433200, 1483932, 16611630.
34. Luan Y, Kong L, Howell DR, Ilalov K, Fajardo M, Bai XH, Di Cesare PE, Goldring MB, Abramson SB, Liu CJ. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis Cartilage 2008, 16:1413-1420. 10.1016/j.joca.2008.03.017, 2574789, 18485748.
35. Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004, 279:10109-10119.
36. Di Cesare PE, Carlson CS, Stolerman ES, Hauser N, Tulli H, Paulsson M. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 1996, 14:946-955. 10.1002/jor.1100140615, 8982138.
37. Maccioni M, Zeder-Lutz G, Huang H, Ebel C, Gerber P, Hergueux J, Marchal P, Duchatelle V, Degott C, van Regenmortel M, Benoist C, Mathis D. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002, 195:1071-1077. 10.1084/jem.20011941, 2193697, 11956298.
38. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D. Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168. 10.1016/S1074-7613(02)00275-3, 11869678.
39. Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol 2004, 34:1208-1216. 10.1002/eji.200424895, 15048732.
40. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580-592.
41. Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, van de Putte LB, van de Winkel JG, van den Berg WB. Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res 2000, 2:489-503. 10.1186/ar131, 17821, 11056679.
42. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692. 10.1126/science.1073176, 12215644.
43. Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, Mathis D, Benoist C. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002, 3:360-365. 10.1038/ni772, 11896391.
44. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzcalis C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009, 6:e1. 2628399, 19166263.
45. Morozzi G, Fabbroni M, Bellisai F, Bellisai F, Pucci G, Galeazzi M. Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments. Ann NY Acad Sci 2007, 1108:398-407. 10.1196/annals.1422.041, 17894003.
46. Turesson C, Bergström U, Jacobsson LT, Truedsson L, Berglund G, Saxne T. Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis 2010, 70:520-522.
47. Kühne SA, Neidhart M, Everson MP, Häntzschel H, Fine PR, Gay S, Häuselmann HJ, RE G. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury. Rheumatol Int 1998, 18:21-15. 10.1007/s002960050049, 9672995.
48. Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom A. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010, 62:3574-3583. 10.1002/art.27720, 20737467.